Cleared Traditional

K240041 - IVD CAPSULE PSP (FDA 510(k) Clearance)

Also includes:
abioSCOPE
Sep 2024
Decision
264d
Days
Class 2
Risk

K240041 is an FDA 510(k) clearance for the IVD CAPSULE PSP. This device is classified as a Immunoassay For Host Biomarkers Of Sepsis (Class II - Special Controls, product code SCX).

Submitted by Abionic SA (Epalinges, CH). The FDA issued a Cleared decision on September 25, 2024, 264 days after receiving the submission on January 5, 2024.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3215. A Semi-quantitative Immunoassay That Measures The Relative Levels Of Host Response Proteins Isolated From Host Blood Or Similar Specimens..

Submission Details

510(k) Number K240041 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 05, 2024
Decision Date September 25, 2024
Days to Decision 264 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code SCX - Immunoassay For Host Biomarkers Of Sepsis
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3215
Definition A Semi-quantitative Immunoassay That Measures The Relative Levels Of Host Response Proteins Isolated From Host Blood Or Similar Specimens.